Bio-Path Holdings Inc (BPTH)
2.10
+0.17
(+8.81%)
USD |
NASDAQ |
May 31, 16:00
2.10
0.00 (0.00%)
Pre-Market: 20:00
Bio-Path Holdings Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.021M |
| March 31, 2022 | |
| December 31, 2021 | -0.023M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.047M |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.017M |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | -0.114M |
| March 31, 2017 | -0.424M |
| December 31, 2016 | -0.313M |
| September 30, 2016 | -0.025M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | -0.0569M |
| September 30, 2014 | -0.0661M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | -0.025M |
| December 31, 2011 | -0.1075M |
| September 30, 2011 | -0.025M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.047M
Minimum
Jun 2021
--
Maximum
Jun 2020
-0.0076M
Average
--
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| INVO Bioscience Inc | -0.0241M |
| Perspective Therapeutics Inc | -47.30M |
| EyePoint Pharmaceuticals Inc | 20.81M |
| Palatin Technologies Inc | 0.00 |
| Lumos Pharma Inc | 1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.038M |
| Cash from Financing (Quarterly) | 0.174M |
| Free Cash Flow | -8.92M |
| Free Cash Flow Per Share (Quarterly) | -1.604 |
| Free Cash Flow Yield | -786.6% |